600488.SHG Tianjin Tianyao Pharmaceuticals Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
5.01 CNY
Close of Nov 5, 2026
3.68 8.44
Market cap
CNY 5.47B
P/E
125.3x
P/B
1.74x
ROE
2.0%
Dividend yield
2.32%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600488.SHG undervalued?

Graham number

The Graham number of Tianjin Tianyao Pharmaceuticals Co Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tianjin Tianyao Pharmaceuticals Co Ltd fundamental analysis

No fundamental analysis for Tianjin Tianyao Pharmaceuticals Co Ltd yet.

Tianjin Tianyao Pharmaceuticals Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tianjin Tianyao Pharmaceuticals Co Ltd

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company's primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, betamethasone product series, and other hormone precursors. The company provides amino acid raw materials, as well as preparations, including injec…

Full company profile